{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:09:33Z","timestamp":1792130973444,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.expneurol.2009.11.014","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T09:35:56Z","timestamp":1259919356000},"page":"320-328","source":"Crossref","is-referenced-by-count":14,"title":["Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin"],"prefix":"10.1016","volume":"221","author":[{"given":"Anna","family":"Tsakiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tsiantoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.expneurol.2009.11.014_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00011-003-1201-9","article-title":"How do statins control neuroinflammation?","volume":"52","author":"Adamson","year":"2003","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.expneurol.2009.11.014_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021425","article-title":"Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin","volume":"197","author":"Aktas","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1-2","key":"10.1016\/j.expneurol.2009.11.014_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0022-1759(98)00056-8","article-title":"A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells","volume":"214","author":"Allsopp","year":"1998","journal-title":"J. Immunol. Methods"},{"issue":"9","key":"10.1016\/j.expneurol.2009.11.014_bib41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/archopht.1978.03910060260015","article-title":"Grating test of contrast sensitivity in patients with retrobulbar neuritis","volume":"96","author":"Arden","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.expneurol.2009.11.014_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.immunol.22.012703.104608","article-title":"CD1: antigen presentation and T cell function 1","volume":"22","author":"Brigl","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.expneurol.2009.11.014_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.410420515","article-title":"Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology","volume":"42","author":"Bruck","year":"1997","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.expneurol.2009.11.014_bib6","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.165.7.3584","article-title":"Monocyte-derived CD1a+and CD1a-dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation","volume":"165","author":"Chang","year":"2000","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4049\/jimmunol.153.3.952","article-title":"Interaction between endothelium and CD4+CD45RA+lymphocytes. Role of the human CD38 molecule","volume":"153","author":"Dianzani","year":"1994","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2004.07.017","article-title":"New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"96","author":"El","year":"2005","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.expneurol.2009.11.014_bib9","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2005-07-2913","article-title":"CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells","volume":"107","author":"Frasca","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.4049\/jimmunol.180.3.1471","article-title":"IFN-gamma arms human dendritic cells to perform multiple effector functions 3","volume":"180","author":"Frasca","year":"2008","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2009.11.014_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0404.1996.tb00515.x","article-title":"Serial MRI, VEP, SEP and biotesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at one year follow up","volume":"93","author":"Frederiksen","year":"1996","journal-title":"Acta Neurol. Scand."},{"issue":"7","key":"10.1016\/j.expneurol.2009.11.014_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajem.2007.01.021","article-title":"Ophthalmic diagnoses in the ED: optic neuritis","volume":"25","author":"Germann","year":"2007","journal-title":"Am. J. Emerg. Med."},{"issue":"8","key":"10.1016\/j.expneurol.2009.11.014_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fj.02-1014fje","article-title":"Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis","volume":"17","author":"Greenwood","year":"2003","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.expneurol.2009.11.014_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.expneurol.2009.11.014_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","article-title":"Immunopathogenesis and immunotherapy of multiple sclerosis","volume":"2","author":"Hemmer","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0165-5728(99)00106-X","article-title":"Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines","volume":"99","author":"Huang","year":"1999","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.expneurol.2009.11.014_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/135245850100700204","article-title":"Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expression","volume":"7","author":"Huang","year":"2001","journal-title":"Mult. Scler."},{"issue":"12","key":"10.1016\/j.expneurol.2009.11.014_bib18","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.21474","article-title":"Axonal loss and myelin in early ON loss in postacute optic neuritis","volume":"64","author":"Klistorner","year":"2008","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2007.08.005","article-title":"Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion","volume":"197","author":"Kofler","year":"2008","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.expneurol.2009.11.014_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1189\/jlb.0905519","article-title":"Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO","volume":"82","author":"Krause","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib40","first-page":"185","article-title":"The desaturated panel D-15. Doc","volume":"46","author":"Lanthony","year":"1978","journal-title":"Ophthalmol."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2249.2007.03367.x","article-title":"Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells","volume":"148","author":"Macdonald","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"Pt. 1","key":"10.1016\/j.expneurol.2009.11.014_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/brain\/121.1.3","article-title":"The role of magnetic resonance techniques in understanding and managing multiple sclerosis","volume":"121","author":"Miller","year":"1998","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.expneurol.2009.11.014_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"issue":"35","key":"10.1016\/j.expneurol.2009.11.014_bib25","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/138161207782794194","article-title":"Emerging indications for statins: a pluripotent family of agents with several potential applications","volume":"13","author":"Paraskevas","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.expneurol.2009.11.014_bib26","doi-asserted-by":"crossref","first-page":"e1928","DOI":"10.1371\/journal.pone.0001928","article-title":"Oral high-dose atorvastatin treatment in relapsing\u2013remitting multiple sclerosis","volume":"3","author":"Paul","year":"2008","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1523-1747.2003.12429.x","article-title":"Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells 6","volume":"121","author":"Pena-Cruz","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"1-2","key":"10.1016\/j.expneurol.2009.11.014_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2006.06.005","article-title":"Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis","volume":"178","author":"Peng","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.expneurol.2009.11.014_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2009.11.014_bib30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","article-title":"Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha","volume":"179","author":"Sallusto","year":"1994","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib31","first-page":"9","article-title":"Dendritic cells (I): biological functions 4","volume":"46","author":"Satthaporn","year":"2001","journal-title":"J. R. Coll. Surg. Edinb."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.53.3.473","article-title":"Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey","volume":"53","author":"Sorensen","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.20914","article-title":"Statins and the blood-brain barrier: plugging the holes","volume":"60","author":"Stuve","year":"2006","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-3083.2006.01728.x","article-title":"Characterization of monocyte-derived dendritic cells maturated with IFN-alpha","volume":"63","author":"Svane","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"1-2","key":"10.1016\/j.expneurol.2009.11.014_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2006.06.006","article-title":"Statins in the treatment of central nervous system autoimmune disease","volume":"178","author":"Weber","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.expneurol.2009.11.014_bib36","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archneur.61.10.1613","article-title":"Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease","volume":"61","author":"Weiner","year":"2004","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2009.11.014_bib37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.expneurol.2009.11.014_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11910-007-0037-z","article-title":"The role of dendritic cells in multiple sclerosis","volume":"7","author":"Wu","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.expneurol.2009.11.014_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2003.10.002","article-title":"HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis","volume":"172","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488609004725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488609004725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T19:44:16Z","timestamp":1685216656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488609004725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0014488609004725"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2009.11.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}